Top compounds associated with response to ZNF397


Feature Type Standardized
Nominal ANOVA
mRNA tivozanib CTRPv2 pan-cancer AAC 0.041 0.3
mRNA tosedostat CTRPv2 pan-cancer AAC 0.1 0.008
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.04 0.3
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 1e-07
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.16 6e-07
mRNA trifluoperazine CTRPv2 pan-cancer AAC 0.086 0.03
mRNA triptolide CTRPv2 pan-cancer AAC 0.063 0.09
mRNA tubastatin A CTRPv2 pan-cancer AAC 0.23 8e-06
mRNA tubastatin A GDSC1000 pan-cancer AAC 0.12 0.0002
mRNA valdecoxib CTRPv2 pan-cancer AAC 0.13 0.0008
Download CSV